Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol in Acute Exacerbations of COPD
NCT00446667Phase 2Withdrawn
- Sponsor
- Syntara Limited
- Start
- Oct 2006
- Primary completion
- Jun 2008
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bronchitol in chronic obstructive pulmonary disease (COPD), sponsored by Syntara Limited. Planned start Oct 2006; status: withdrawn.
02
Drugs
Bronchitol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00446667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446667.